What Does Science Say About Gender?

Science treats sex and gender as related but distinct phenomena, and the research across genetics, neuroscience, endocrinology, and psychology consistently reveals that both are more complex than a simple two-category system. Biological sex itself involves chromosomes, hormones, gonads, and anatomy that do not always align neatly, while gender identity appears to emerge from an interplay of prenatal hormones, genetics, epigenetics, and social experience. The picture that has solidified over the past two decades is one of overlap, variability, and mosaics rather than clean divisions.

Sex Is Biological but Not Binary in the Way Most People Assume

The common understanding of biological sex starts with chromosomes: XX typically leads to female development, XY to male. That framework is broadly accurate, but treating it as absolute misses a meaningful portion of human biology. Sex determination involves a cascade of genetic signals, and when any step in that cascade varies, the result can fall outside the expected pattern. Disorders of sex development (DSDs) encompass a spectrum of conditions where chromosomal, gonadal, and anatomical sex do not match up. Advances in genetic technology have revealed that mutations in sex-determining genes, copy number variations, and epigenetic changes can all disrupt the typical pathway.¹

Chromosomal variation alone is more common than many people realize. The most frequent sex chromosome abnormalities include Turner syndrome (a single X chromosome), Klinefelter syndrome (XXY), Trisomy X (XXX), and Double Y syndrome (XYY).² People with these conditions may go through much of life without knowing their chromosomes differ from the assumed pattern. And chromosomes are only the beginning: the SRY gene on the Y chromosome usually triggers male development, but rare cases exist where people with XX chromosomes develop male anatomy because a different gene, like SOX3, duplicates and takes over that role. Researchers have documented familial cases of XX individuals who appeared phenotypically male, had normal testosterone levels, and lacked the SRY gene entirely.³ These are not abstract curiosities; they demonstrate that “biological sex” is the outcome of dozens of genetic instructions, any of which can vary.

The Brain Is a Mosaic, Not a Pink or Blue Organ

One of the most persistent popular beliefs about gender is that male and female brains are fundamentally different, wired for different abilities and temperaments. Neuroscience has spent decades investigating this claim, and the findings are far more nuanced than the headlines suggest. A landmark study analyzing MRI scans from more than 1,400 brains found extensive overlap between males and females across all measures of gray matter, white matter, and neural connections. Brains that were internally consistent, showing only “male-typical” or only “female-typical” features across multiple regions, were rare. Instead, most brains were unique mosaics, combining features more common in one sex with features more common in the other.⁴

This mosaic hypothesis has been replicated and expanded. Follow-up work confirmed that the brain “types” typical of women are also typical of men, and vice versa, meaning you cannot reliably determine someone’s sex by scanning their brain structure.⁵ A review of this literature concluded that sex category explains only a small part of the variability in brain structure, and that mosaic brains reside in a multidimensional space that cannot be meaningfully reduced to a male-female continuum.⁶

This does not mean there are zero statistical differences between groups. There are measurable average differences in certain brain regions, and sex steroid hormones during fetal development do influence brain organization. Testosterone, estrogen, and dihydrotestosterone play roles in shaping structures like the hypothalamus, the bed nucleus of the stria terminalis, and parts of the limbic system.⁷ But these average group differences are swamped by within-group variation. Knowing someone’s sex tells you very little about the specific architecture of their individual brain.

What Prenatal Hormones and Epigenetics Actually Do

The idea that prenatal hormones “organize” the brain for gender, locking in personality traits and cognitive patterns, is a theory with a long history. Research on people with congenital adrenal hyperplasia (CAH), a condition where genetic females are exposed to unusually high levels of androgens before birth, is often cited as key evidence. People with CAH do show some shifts in play preferences and spatial ability on average. But this research also illustrates the difficulty of separating hormonal effects from social ones: children with CAH often have visible genital differences at birth, which can change how parents and doctors treat them from day one.⁸

Epigenetics adds another layer. In the brain’s preoptic area, which is important for sexual behavior, the chemical marks on DNA and the proteins that package it differ between sexes during early development. These marks regulate how actively certain genes are expressed, and they appear to carry forward the effects of both hormonal exposure and early social experience. Maternal care during postnatal development, for instance, has a lasting effect on gene expression in this region, mediated by DNA methylation.⁹ The takeaway is that sex-related brain differences are not purely genetic or purely hormonal. They emerge from a layered process where genes, hormones, epigenetic modifications, and the postnatal environment all interact. That makes simple claims like “gender is hardwired” or “gender is entirely socially constructed” equally incomplete.

Gender Identity in Transgender People

A growing body of neuroimaging research has examined the brains of transgender individuals. One study found that the brains of transgender women fell between those of cisgender men and cisgender women on structural measures, shifted away from their birth sex toward their gender identity. The differences from both cisgender groups were statistically significant.¹⁰ A systematic review of the neuroimaging literature found structural differences between cisgender and transgender groups in white matter, brain volume, cortical thickness, and specific subcortical structures like the putamen.¹¹ More recent work using functional MRI also showed differences in local brain activity and connectivity patterns in transgender women compared to cisgender participants.¹²

These findings are suggestive but come with important caveats. Sample sizes in most of these studies are small, and the overlap between groups is large. No brain scan can diagnose someone’s gender identity. What the research does indicate is that gender identity has measurable biological correlates and is not simply a belief or preference. Genetic studies looking for specific genes linked to gender incongruence have so far been inconclusive. A systematic review and meta-analysis of genetic association studies in transgender cohorts concluded that future work should use broader genome-wide methods rather than focusing on individual candidate genes.¹³ In short, there is likely some genetic contribution, but we do not yet know its size or which genes are involved.

How Stable Is Gender Identity in Children?

A common concern is that children who identify as transgender are going through a phase. A large longitudinal study tracked early-identifying transgender youth, their siblings, and an unrelated comparison group over time. Stability in gender identity was the most common pattern across all three groups, with over 80% of children showing no change throughout the study period. When change did occur, it typically involved movement to or from a nonbinary identity rather than a wholesale reversal. Critically, the transgender children’s sense of their own gender was no more or less stable than their cisgender peers’, suggesting that supported transgender identities follow the same developmental trajectory as cisgender ones.¹⁴

This matters because earlier research, often cited in policy debates, drew from clinics where children were referred for gender-related distress and where many had not socially transitioned. Those samples showed higher rates of what was called “desistance,” but the populations are not comparable to children who have been socially transitioning and are supported in their identities from an early age.

Mental Health and Gender-Affirming Care

Transgender and gender-diverse people face significantly higher rates of depression, anxiety, and suicidality than the general population. The gender minority stress framework attributes these disparities not to being transgender itself but to the external stigma, discrimination, and rejection that transgender people experience.¹⁵ Among youth specifically, both external stressors like family rejection and internal stressors like internalized stigma drive mental health disparities.¹⁶

Research on gender-affirming medical care has found meaningful benefits. A study of transgender and nonbinary youth found that those who had started puberty blockers or gender-affirming hormones had roughly 60% lower odds of depression and 73% lower odds of suicidality compared to those who had not, after adjusting for confounders. No association was found with anxiety.¹⁷ A systematic review similarly found that gender-affirming interventions led to significant improvement in mental health and body image acceptance.¹⁸ Affirming psychosocial interventions have also been linked to reduced distress, anxiety, and suicidality, while restrictive policies were associated with poorer mental health outcomes.¹⁹

The evidence here is strong enough that most major medical organizations endorse gender-affirming care, but it is worth noting that most studies are observational rather than randomized, and many come from populations in higher-income countries. The research base is growing quickly but remains somewhat limited in geographic diversity.

Physical Health Considerations

Gender-affirming hormone therapy has physical effects beyond the intended changes in secondary sex characteristics. Puberty blockers, specifically GnRH agonists, produce expected physiological outcomes under specialist care, but around two years of treatment can slow bone mass accumulation, reduce growth velocity, and increase fat mass. Common side effects include hot flashes, mood changes, fatigue, and headache.²⁰ During treatment, gonadotropins and sex steroids drop markedly in both transgender boys and transgender girls, with changes in body composition that are more pronounced than those seen in cisgender adolescents.²¹

For adults, the picture depends on the direction of treatment. Current evidence from non-randomized studies suggests that transgender women taking estrogen-based hormone therapy have increased risks of heart attack, stroke, and blood clots. The same elevated cardiovascular risk has not been found in transgender men receiving testosterone. Estrogen therapy does appear to benefit bone density in the lower spine for transgender women.²² These findings highlight why medical monitoring during hormone therapy matters, particularly for cardiovascular markers in transgender women.

Changing Demographics and Diagnosis Patterns

The visibility of gender-diverse identities has increased sharply over the past decade, and the clinical data reflect that. In England, recorded incidence of gender dysphoria and gender incongruence in children and young people rose from about 0.14 per 10,000 person-years in 2011 to 4.4 per 10,000 in 2021, with the increase more rapid among those recorded as female at birth from 2014 onward.²³ In the United States, the mean age at gender dysphoria diagnosis fell from about 31.5 in 2017 to roughly 26 in 2021. Among those assigned female at birth, the peak age of diagnosis was 19; for those assigned male at birth, it was 23.²⁴

Over a longer time frame, the ratio of transgender women to transgender men seeking hormone therapy has also shifted. Historically, transgender women outnumbered transgender men in clinical settings, but over the past 25 years the proportion of transgender men has risen steadily until it is now roughly equal. The mean age at initiation of hormone therapy has also dropped, falling below 30 since 2015.²⁵ Whether these trends reflect a genuine increase in prevalence, greater social acceptance that allows more people to come forward, better access to clinical services, or some combination of all three is an active area of debate. The data alone cannot distinguish between more people experiencing gender incongruence and more people being comfortable reporting it.

How Medical Classification Has Shifted

The way medicine categorizes gender-related experiences has changed substantially. A diagnosis of “transsexualism” first appeared in the DSM-III in 1980. Successive editions revised the terminology and criteria, influenced not only by research but also by social and political factors.²⁶ The DSM-5, published in 2013, replaced “Gender Identity Disorder” with “Gender Dysphoria,” a shift designed to focus on distress rather than identity itself as pathological. The WHO’s ICD-11, approved in 2019, went further, introducing “Gender Incongruence” and placing it not in the mental health chapter but in a chapter on sexual health.²⁷ That reclassification was significant: it preserved access to healthcare under insurance frameworks that require a diagnostic code, while removing the implication that being transgender is a mental illness.

The earlier medical history stretches back much further than the DSM. Cross-gender behavior entered medical discourse during the eighteenth century, initially framed around male cross-dressing. By the late 1800s, researchers like Krafft-Ebing were developing more substantive theories about what they called “sexual inversion,” though these were tangled up with ideas about sexuality that would later be recognized as separate phenomena.²⁸ The conceptual separation of gender identity from sexual orientation is itself a relatively modern achievement, and one that research has reinforced: the two involve different neural and psychological processes.

Sex Differences That Matter in Medicine

While the “male brain vs. female brain” framing collapses under scrutiny for cognition and personality, biological sex does have concrete medical relevance. The immune system is one of the clearest examples. Males tend to be more susceptible to severe viral illness and certain cancers, while females mount a more vigorous immune response, which is protective against infection but also makes them more prone to autoimmune conditions. These differences are governed by a mix of genetics, sex hormones, and environmental factors.²⁹ Sex steroid hormone receptors are found across diverse cell types, meaning sex can affect the function of essentially every physiological system, including how the body processes drugs.³⁰

Pharmacology is another area where sex differences have real consequences. Men and women differ in how they absorb, distribute, metabolize, and eliminate drugs. These differences, along with pregnancy-related changes, can be significant enough to warrant changes in dosing or therapeutic monitoring for certain medications.³¹ For decades, clinical trials disproportionately enrolled male participants, meaning many drug dosages were calibrated for male bodies. That legacy is still being corrected.

Gender Across Cultures and Species

The idea that gender neatly divides into two categories is not universal even within human societies. Cultures across South and Southeast Asia have long recognized identities that do not map onto a Western male-female binary. The hijra of South Asia, the bakla of the Philippines, and the waria of Indonesia all represent culturally specific gender roles with deep historical roots. Colonial enforcement of European binary gender norms disrupted many of these traditions, with diverse consequences across different societies.³² The existence of these identities across independent cultural lineages suggests that the human experience of gender has always been broader than a strict binary, even if many societies organized themselves around one.

Biology itself offers perspective here. Among fish, sequential hermaphroditism is common. Some species change from male to female, others from female to male, and some can change in either direction depending on social circumstances.³³ Clownfish, for instance, are protandrous hermaphrodites: they begin life as males and can become female, with the transformation coordinated across behavior, anatomy, neuroendocrine function, and gene expression. The aromatase gene, which converts androgens to estrogens, plays a central role in this process both in the brain and the gonads.³⁴ None of this means that fish sex change is analogous to human gender identity. But it does illustrate that rigid sexual dimorphism is not a universal law of biology. Nature has evolved a wide variety of strategies, and strict binary sex is just one of them.

Cognitive Differences and What the Data Actually Show

Claims about cognitive differences between men and women are a perennial source of debate. A recent meta-analysis looked at variance ratios across multiple cognitive domains using standardized IQ tests for children. It found that male scores did show slightly greater variance than female scores in some areas, including general intelligence and crystallized ability, while females showed slightly greater variance in processing speed. But all of these effects were small. The largest difference amounted to one sex having roughly 8% more variance than the other, meaning the distributions overlap almost entirely.³⁵ In practical terms, knowing a child’s sex tells you almost nothing useful about their cognitive profile. The within-sex variation dwarfs the between-sex variation, which echoes what the brain mosaic research found at the structural level.